GLOBAL, 21 September 2026 — Ethena’s ENA token rose 10.67% to $0.221698 and AAVE gained 7.77% to $145.28 in CoinGecko’s synchronized market response. Both also appeared in the provider’s search-trending list.

Two-token DeFi comparison

Measure ENA AAVE
Price $0.221698 $145.28
24-hour change +10.67% +7.77%
Seven-day change +60.34% +16.37%
Reported volume $749.93 million $354.88 million
Market value $2.24 billion $2.24 billion

Similar market size, different turnover

The two assets had almost equal reported market capitalisations, but ENA’s daily turnover was more than twice AAVE’s. That difference describes trading intensity during the window; it does not rank protocol quality or imply that one token has superior liquidity under every condition.

Single-venue verification

Kraken showed ENA near $0.2218 and AAVE near $145.09, broadly aligning with the aggregates. The venue’s ranges were $0.1992–$0.2305 for ENA and $134.28–$149.29 for AAVE. Readers should not treat the extremes as guaranteed support or resistance.

Why DeFi needs protocol-specific evidence

Ethena and Aave have different products, governance structures and risk exposures. Official documentation should be used for protocol mechanics. Token appreciation does not by itself demonstrate deposits, revenue, reserves, solvency or adoption.

Limits of the sector label

“DeFi” is a useful discovery category, but it can conceal material differences in collateral, oracle dependence, governance authority and redemption mechanics. The common price direction is therefore reported as a market observation rather than evidence that the two protocols experienced the same underlying event.

Next useful checks

A rigorous follow-up would compare protocol-controlled metrics, governance proposals and independently defined liquidity readings. CapKet will not merge those measurements into the price story unless their timestamps and methodologies are explicit.

Disclosure: DeFi tokens carry smart-contract, market, liquidity and governance risks. This is general financial news, not investment advice or a protocol endorsement.